The ENTIS Board are delighted to announce that Brachia Stahl, Beilinson Teratology Information Service (BELTIS), has been awarded an honorary ENTIS membership for her outstanding contribution and lifelong commitment to teratology counselling. The award was presented on behalf of the ENTIS board by Dr Orna Diav-Citrin during a Teratology Symposium which was assembled in Bracha’s honour and hosted at the Assaf Harofe Medical […]
» Read more
ENTIS are pleased to confirm that the 30th conference of the European Network of Teratology Information Services will take place between Thursday 5th and Saturday 7th September 2019 in Oslo, Norway. More details will be following shortly, so please keep an eye on the website for further announcements.
» Read more
Between the 4th and 8th September, UKTIS hosted the UK’s first Human Teratogens Education Course and the 3rd International Joint Meeting of the European Network of Teratology Information Services (ENTIS) and Organization of Teratology Information Specialists (OTIS) in Newcastle upon Tyne. Delegates attended from around the globe and were treated to presentations from some of the most influential researchers and […]
» Read more
A collaborative ENTIS study recently published in Reproductive Toxicology (Volume 67, Pages 26-34) has provided no signal that varenicline is a major human teratogen. This collaborative ENTIS study was undertaken by researchers based at teratology information services in the United Kingdom, Israel, France (Paris), Germany (Berlin), Australia, the Netherlands, Finland and Turkey (Izmir), who collectively joined data from over 400 […]
» Read more
Changing of the Guards: EMA Warning on Paternal Use of Mycophenolate Mofetil: An Unnecessary and Insufficiently Substantiated Precaution. Damkier P, Passier A, Petersen LB, Havnen G, Petersen AJT. Birth Defects Res A Clin Mol Teratol. 2016 Sep 28. doi: 10.1002/bdra.23556 In this commentary, we strongly argue against the changes to the Summary of Product Characteristics (SmPC) made by European Medicines […]
» Read more
A collaborative ENTIS study published in Neurology found an increased frequency of major malformations following exposure to pregabalin during the first trimester of pregnancy. Eight member centers of the European Network for Teratovigilance Information Services (ENTIS) conducted a study, which aimed at recording the incidence of malformations after pregabalin use during the first trimester of pregnancy [1]. Pregabalin, an anti-seizure drug, is […]
» Read more